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Acute radiation syndrome or acute radiation sickness is classically subdivided into three
subsyndromes: the hematopoietic, gastrointestinal and neurovascular syndrome but many
other tissues can be damaged. The time course and severity of clinical signs and symptoms
are a function of the overall body volume irradiated, the inhomogeneity of dose exposure,
the particle type, the absorbed dose and the dose rate. Classical pathophysiology explain
the failure of each of these organs and the timing of appearance of their signs and symp-
toms due to radiation-induced cytocidal effects of a great number of parenchymal cells of
hierarchically organized tissues. Contemporaneously, many other radiation-induced effects
has been described and all of them may lead to tissue injury with their corresponding signseurovascular syndrome
adiation-induced multi-organ
nvolvement
adiation-induced multi-organ
ailure
and symptoms that can be expressed after short or long period of time. Radiation-induced
multi-organ involvement is thought to be due to radiation-induced systemic inﬂammatory
response mediated by released pro-inﬂammatory cytokines.
© 2011 Greater Poland Cancer Centre, Poland. Published by Elsevier Urban & Partner Sp.
z.o.o. All rights reserved.
contamination. The purpose of this paper is to describe the. Introduction
cute radiation syndromeor acute radiation sickness is a term
sed to describe a constellation of signs and symptoms that
ccurs after whole-body or signiﬁcant partial-body irradiation
f certain amount of radiation (>0.5Gy) delivered at high-dose
ate. These signs and symptoms are the consequences of
evere radiation damage to speciﬁc tissues of speciﬁc organs
mono-organ involvement) although many tissues can be
amaged (multi-organ involvement). The ﬁrst description
f acute radiation syndrome was made by De-Coursey after
∗ Corresponding author. Tel.: +34 93 260 77 20; fax: +34 93 260 77 25.
E-mail addresses: mmacia@iconcologia.net, 16458mmg@comb.es (M
507-1367/$ – see front matter © 2011 Greater Poland Cancer Centre, Poland
oi:10.1016/j.rpor.2011.06.001atomic bomb explosions in Japan during World War II in
1945.1 Other sources of human data come from radiation
accidents as Chernobyl nuclear power plant disaster as well
as clinical data of patients undergoing total body irradia-
tion as part of their cancer therapy. This syndrome differs
from others radiation exposures as acute partial irradiation,
chronic radiation syndrome or external and internal particle. Macià i Garau).
underlying pathologic mechanisms that explain the clinical
course of humans exposed acutely to a large single radiation
exposure until recovery or death.
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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Table 1 – Signs and symptoms of prodromal phase.4
Signs and
symptoms
Mild (1–2Gy) Moderate (2–4Gy) Severe (4–6Gy) Very severe (6–8Gy) Lethal (>8Gy)
Vomiting
Onset
% of incidence
≥2h after
exposure
10–50
1–2h after
exposure
70–90
<1h after
exposure
100
<30min after
exposure
100
<10min after
exposure
100
Diarrhea
Onset
% of incidence
None None Mild
3–8h
<10
Heavy
1–3h
>10
Heavy
Within min
100
Headache
Onset
% of incidence
Slight Mild Moderate
4–24h
50
Severe
3–4h
80
Severe
1–2h
80–90
Consciousness
Onset
% of incidence
Unaffected Unaffected Unaffected May be altered Unconsciousnes
s/min
100 at >50Gy
Fev
1–2
80–Body temperature
Onset
% of incidence
Normal Increased
1–3h
10–80
Classically, acute radiation syndrome is subdivided into
three subsyndromes: the hematopoietic syndrome, the gas-
trointestinal syndrome and the neurovascular syndrome.
Classical radiobiology explain the failure of each of these
organs by radiation-induced death (cytocidal effects) of a great
number of parenchymal cells (target cell theory) but today
we know that radiation not only cause lethal effects but also
functional and indirect effects in many cells (multi-cellular
target theory).2 Contemporaneously, a new syndrome called
radiation-induced multi-organ dysfunction is believed to be
part of acute radiation syndrome. The pathophysiological
mechanism of radiation induced multiple organ failure is not
clear but evidence has accumulated suggesting a major role
of damaged endothelial cells leading to a radiation-induced
systemic inﬂammatory response syndrome mediated by the
release of inﬂammatory cytokines.3,20
The time course and severity of clinical signs and symp-
toms are a function of the overall body volume irradiated, the
inhomogeneity of dose exposure, the absorbed dose, the dose
rate and the particle type. There are four clinical phases in the
development of radiation sickness:
- Prodromal phase: is the initial phase of acute illness. Signs
and symptoms appear within 1–3 days after the exposure
and are characterized by nausea, vomiting, anorexia, fever,
headache and early skin erythema. Depending on the dose
received these symptoms can be mild viral like or severe.
The onset of vomiting is also relatedwith absorbed dose and
can be seen within few minutes after a high dose exposure.
- Latent phase: is a delusive phase characterized by improve-
ment of symptoms and an apparent cure. Individuals look
and fell good but laboratory tests become abnormal with
lymphopenia and granulocytopenia. This phase is also dose
dependent and may last hours to weeks.
- Manifest illness phase: in this phase speciﬁc signs and
symptoms of each syndrome appear depending on the dose.
The hematopoietic syndrome develops at doses of between
1 and 8Gy although slight decrease in blood cell counts
can be seen with doses below 1Gy. The gastrointestinal
syndrome occurs at doses of between 5 and 20Gy and the
cerebrovascular syndrome at doses higher than 20Gy.er
h
100
High fever
<1h
100
High fever
<1h
100
- Final phase: recovery or death depending on the absorbed
dose, dose rate and the heterogeneity of exposure.
A good summary of signs and symptoms and their cor-
relation with absorbed doses has been published by the
International Atomic Energy Agency (IAEA) and is reproduced
in Tables 1–3.4 The time course and severity of clinical signs
and symptoms are summarized in Table 4.5
To understand the signs and symptoms due to parenchy-
mal cell depletion caused by radiation (target cell theory) and
their onset is useful to knowhowmammalian tissues are orga-
nized.
2. Type of organization of mammalian
adult normal tissues
A tissue is a group of cells from the same origin that carry
out a speciﬁc function. Mammalian adult normal tissues are
populations of particular cell lineage (same type of cells) that
maintain their number and have a particular type of orga-
nization. Under normal conditions, the number of cells is
homeostatically controlled and well balanced between the
production of news cells and the loss of adult mature cells
dying after a ﬁnite lifespan. In contrast to tumors, physio-
logic growth or post-injury status, adult normal tissues are
population of cells in equilibrium.
We can distinguish two models of tissue organization6:
- Hierarchical model organization (H-type model), also called
tissues with rapid cell turnover or proliferative tissues. The
main characteristic of this organization is the presence of
several cell compartments (compartmental tissues)(Fig. 1a)
where the tissue-speciﬁc function is restricted to mature
non-proliferative cells. Three compartments can be distin-
guished:
• Stem cell compartment: is an small compartment com-
posed by stem cells capable of unlimited divisions and
a self-renewing capacity to maintain their number and
provide cells to enter in the ampliﬁcation compartment.
These cells are incapable of tissue-speciﬁc function. The
crypt cells in the intestinal epithelium, bonemarrowstem
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Table 2 – Signs and symptoms of latent phase.4
Signs and symptoms Mild (1–2Gy) Moderate (2–4Gy) Severe (4–6Gy) Very severe (6–8Gy) Lethal (>8Gy)
Latency period 21–35 days 18–28 days 8–18 days ≤7 days None
Lymphocytes G/L (days 3–6) 0.8–1.5 0.5–0.8 0.3–0.5 0.1–0.3 0.0–0.1
Granulocytes G/L >2.0 1.5–2.0 1.0–1.5 ≤0.5 ≤0.1
Diarrhea None None Rare Appears on days 6–9 Appears on days
4–5
Depilation None Moderate,
beginning on day
15 or later
Moderate, beginning
on day 11–21
Complete earlier
than day 11
Complete earlier
than day 10
Table 3 – Signs and symptoms of critical phase.4
Signs and symptoms Mild (1–2Gy) Moderate (2–4Gy) Severe (4–6Gy) Very severe (6–8Gy) Lethal (>8Gy)
Onset of symptoms >30 days 18–28 days 8–18 days <7 days <3 days
Clinical manifestations Fatigue,
weakness
Fever, infections,
weakness,
depilation
High fever,
infections, bleeding,
depilation
High fever, diarrhea,
vomiting, dizziness,
desorientation,
hypotension
High fever,
diarrhea,
unconsciousness
Lymphocytes G/L (days 3–6) 0.8–1.5 0.5–0.8 0.3–0.5 0.1–0.3 0.0–0.1
Platelets G/L 60–100 30–60 25–35 15–25 <20
4
2
4% of incidence 10–25 25–40
Lethality 0% 0–50%
Onset time 6–8 week
cells or stem cells in the basal layer of the epidermis are
examples of this compartment.
• Differentiating compartment or ampliﬁcation compart-
ment: in this compartment, the descendants of the
stem cells are in the process of maturation. They are
actively proliferating and differentiating. They are acquir-
ing functional capacity while their proliferation becomes
increasingly limited (subclonogenicity) and they are the
precursors of mature cells. Cells of the basal layer
of epidermis and erythroblasts are examples of this
compartment.Both compartments are constituted by pro-
liferating cells, stem cells more slowly than precursors
cells.• Post-mitotic compartment or mature functioning com-
partment: is a compartment composed by mature, fully
differentiated and functional competent cells. They are
Table 4 – The time course and severity of clinical signs and sym
Absorbed
dose level
Prodromal phase Latent phas
0.5–1.5Gy Absence of symptoms or
nausea and vomiting for 1
day
1 day–severa
weeks
1.5–4Gy Nausea, vomiting, fatigue,
weakness, diarrhea for up
to two days
1–3 weeks
4–6Gy Nausea, vomiting,
weakness, diarrhea for up
to two days
<1–3 weeks
6–15Gy Severe nausea and
vomiting, diarrhea in
shorter period of time
Several days
>15Gy Immediate severe nausea
and vomiting
Non-existent
Modiﬁed from Ref. 5.0–80 60–80 80–100
0–70% 50–100% 100%
–8 week 1–2 week 1–2 week
not able to divide and give the function of the tissue. After
their lifespan, variable betweendifferent tissues, they die.
Examples of this compartment are the cells in the surface
layers of epidermis, cells at the top of villi of intestinal
mucosa or mature circulating blood cells.
Cell depletion caused by any kind of injury will be com-
pensated by triggering the surviving stem cells to proliferate
quickly. This phenomenon is known as compensatory repop-
ulation or accelerated proliferation (Fig. 1b).
Examples of hierarchically organized tissues are the
haematopoietic tissue, buco-pharyngeal and intestinal
mucosa, testicular epithelium and epidermis. These tis-
sues have a rapid cell turnover, for example the turnover
of epidermis is nearly three weeks and three days for
intestinal mucosa. The average life of granulocytes is less
ptoms.
e Manifest illness Final phase
l No symptoms or weakness,
nausea and vomiting,
temporary hair loss
Recovery
Hematopoietic syndrome
(HS): leucopenia and
trombocitopenia, hair loss
Recovery possible
with supportive care
HS: bleeding,
immunosuppression and
sepsis, permanent hair loss
Death without
supportive care
HS+gastrointestinal
syndrome: diarrhea,
bleeding, ﬂuid loss and
electrolyte imbalance
Variable with
supportive care
Neurovascular syndrome Death within 48h
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Fig. 1 – (a) Hierarchical model of tissue organization. (b)
Response of hierarchical model of tissue organization in
front of a cell depletion caused by injury.
relates with the lifespan of mature cells and the latent period
is predictable and short (Fig. 3).than one day, 8–10 days for platelets and 120 days for
erythrocytes.
Flexible model organization (F-type model), also called tis-
sues with slow cell turnover. They have no compartments
(mono-compartmental tissues) and no hierarchy (Fig. 2a).
The tissue is composed of identical cells with tissue-speciﬁc
function and clonogenicity (capacity for cell renewal). The
archetype of non-hierarchically organized tissue are the hep-
atocytes. All of them are functionally competent, the majority
residing in phase G0 although they retain their proliferative
potential. These tissues have a slow cell turnover, the average
life of hepatocytes is one year.
Table 5 – Differences between H-type and F-type models of nor
Properties
Proliferative capacity of functional cells
Physiological rate of turnover of functional cells
Time-scale of expression of radiation injury
Time onset of functional damage
Dose-response relationship
˛/ˇ ratio (Gy)iotherapy 1 6 ( 2 0 1 1 ) 123–130
Cell depletion caused by any kind of injury as after partial
hepatectomy, will be compensated by triggering the surviving
functional cells to proliferate parasynchronously faster (accel-
erated rate of proliferation) (Fig. 2b).
The differential characteristics of the two models are
shown in Table 5. It has been proposed that these two mod-
els are extreme ends of a spectrum of proliferative tissues
and that some real tissues may be more appropriately rep-
resented by hybrid models incorporating some properties of
each of the two models.7 In any case, the distinction between
these two models is useful to understand the differences in
the radio-response.
3. Target cell theory
The historical mechanistic model of injury is that radiation-
induced normal tissue damage consists of two distinct and
separate phases, an acute and a late phase each due to the
depletion of different target cell populations. Early or acute
effects result from the death of a large number of proliferat-
ing cells hierarchically organized and delayed or late effects
result from the death of a large number of parenchymal cells
organized in a ﬂexible manner. As the most important mode
of cell death following irradiation is mitotic cell death that
results from DNA damage, the time between irradiation and
manifestation of injury (latency interval) will depend on target
cell characteristics and tissue organization.
Hierarchically organized tissues composed by proliferat-
ing cells with rapid cell turnover will express their radiation
damage early dying in mitosis within a few days. Mature func-
tional cell of this kind of tissues are non-proliferating, not
cycling, then they will remain relatively unaffected by radi-
ation because they cannot die in mitosis. After their lifespan,
they will die at their physiologic rate. For this reason, the rate
of radiation-induced depopulation of functional cells is largely
dose-independent. In summary, irradiation of hierarchical tis-
sues depletes stem and progenitor proliferating cells but has
not direct effect on mature functional competent cells. Tis-
sue injury and the development of signs and symptoms will
result from the failure of proliferating cells to replenish the
post-mitotic compartment ofmature cellwhich continue to be
lost at the normal physiologic rate. The intensity of signs and
symptoms is related with the absorbed dose and the number
of stem cells killed but the time of onset of these reactions cor-On the other hand, non-hierarchically organized or ﬂexible
tissues are composed of functional slowly proliferating cells
mal tissues and their response to irradiation.6
H-type model F-type model
None Inﬁnite
Rapid Slow
Early Late
Dose-independent Dose-dependent
Short shoulder Large shoulder
Large (∼10–15Gy) Short (∼2–3Gy)
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Fig. 2 – (a) Flexible model of tissue organization. (b) Response of ﬂexible model of tissue organization in front of a cell
d
w
m
t
m
F
s
sepletion caused by injury.
ith slow cell turnover. The expression of injury caused by
itotic cell death and the development of signs and symp-oms is dose-dependent and the latency period is long of
onths or years.
ig. 3 – Graph showing the dose-independence of onset of
igns and symptoms and the dose-dependence of their
everity.4. Hematopoietic syndrome
Hematopoietic stem cell and progenitors cells of the bone
marrow that are rapidly dividing cells (stem cell compart-
ment and differentiating compartment) are highly sensitive
to the effects of ionizing radiation. Animal studies indicate
that hematopoietic stem cells have a D0 of about 0.95Gy.8
It means that a dose of 0.95Gy reduces the population of
stem cells to 37%. For this reason, hematopoietic syndrome
is seen with radiation exposures exceeding 1Gy. At doses
below 1Gy, surviving proliferating cells (through accelerated
proliferation) will be able to replenish mature functioning
compartment and only an insigniﬁcant clinical decrease in
blood cell counts can be seen. As the absorbed dose increases,
more and more hematopoietic stem cell and precursors cells
will be killed and only a few cells or no cells will enter in post-
mitotic compartment. Mature circulating cells unaffected by
radiation will die after their lifespan at their physiological
rate. The onset of signs and symptoms will appear depend-
ing on the physiological cellular loss rate of circulating cells
and the dose-dependent reduced supply of mature cells
from the depleted proliferating compartments. The balance
between these two phenomena results in different degree of
d rad128 reports of practical oncology an
pancytopenia with predisposition to infection due to leu-
copenia and bleeding due to thrombocytopenia. The severity
of signs and symptoms (hypoplasia or aplasia of the bone
marrow) and the probability to recover will depend on the
absorbed dose, the dose rate and the overall bone marrow vol-
ume irradiated. If no regeneration, death usually occurs due
to infection and/or hemorrhage at doses of 4.5–6Gy without
supportive care.
Lymphopenia resulting from radiation-induced apoptosis
occurs before the onset of other cytopenias. It can be seen
within the ﬁrst 6–24h after a moderate or high dose exposure.
The rate of lymphocytic depletion and its nadir is dose-
dependent and can be predicted. This predictability has led
to the development of models using lymphocyte depletion
kinetics as an element of biodosimetry if absorbed dose is
unknown.9 But, as radiation also perturbs recirculation prop-
erties of lymphocytes, their decline cannot be taken as an
indicator of the extent of stem cell damage.10
The onset time and the duration of the nadir of other
cytopenias is also dose-dependent. Granulocytes count may
transiently increase due to the release of mature cells
(not affected by radiation) stored in the bone marrow into
the blood. This transient increase called abortive rise or
stress reaction may be clinical useful because its prognostic
signiﬁcance.11 After their lifespan of about 7–24h, granulo-
cytes disappear from the blood and are replaced in different
degrees depending on the absorbed dose and the number of
few injuredor intact stemcells. Thehigher thedose, the earlier
disappearance of granulocytes.
Circulating platelets that have a lifespan of about 10 days
disappear progressively from the blood within this period of
time and are replaced in different degree or not depending on
the level of damaged stem cells.
Analyzing the early blood cell change patterns (mainly
granulocytes and platelets) after an unknown dose exposition,
biomathematical models has been developed to predict the
effect of radiation on the hematopoietic stem cell pool (possi-
bility of a reversible damage to hematopoiesis or a complete
and irreversible damage of the stem cell pool).12
Anaemia not due to acute hemorrhage is an unusual ﬁnd-
ing because mature red blood cells have a long lifespan of
about four months.
Flt-3 ligand (FL) is a cytokine that acts alone or in combina-
tion with other cytokines such as Stem Cell Factor mainly on
stems cell and progenitor cells regulating cell differentiation
and proliferation (homeostatic mechanism).13 High levels of
FL has been found in patients with aplastic anaemia as well as
in patients undergoing chemo and radiotherapy for bone mar-
row transplantation. It was hypothesized that plasma levels
of FL might be used as an indicator of aplasia after radia-
tion exposure. Bertho et al. showed an increase in plasma FL
concentration as early as day 2 after whole or partial body
irradiation in non-human primates. Increase in plasma FL
concentration on day 5 post-exposure was correlated with
radiation dose and with the severity of radiation-induced
aplasia. Subsequent decrease in FL concentrationwas also cor-
related with the recovery of blood cells population suggesting
that monitoring plasma levels of FL can be used as a bioindica-
tor of bone marrow function.14 These ﬁndings were conﬁrmed
in patients undergoing chemo and radiotherapy as a condi-iotherapy 1 6 ( 2 0 1 1 ) 123–130
tioning regimen for stem cell transplantation15 and used to
assess the severity of radiation-induced damage in a recent
accidental exposure.16
5. Gastrointestinal syndrome
Gastrointestinal syndrome occurs at doses of between 6 and
15Gy. Clinical signs and symptoms are due to the lack of
replacement of cells in the surface of the villi because stem
and proliferating cells located in the crypts are damaged
by radiation and die in mitosis. Between 7 and 10 days
after exposure, the denudation of intestinal mucosa pro-
duces watery diarrhea, dehydratation and electrolyte loss,
gastrointestinal bleeding and perforation. The breakdown of
the mucosal barrier facilitates the entry of bacterias into the
bloodstream. Of course, the immunosuppression associated
with thehematopoietic syndrome favours opportunistic infec-
tions and thrombocytopenia favours hemorrhage. Death from
the gastrointestinal syndrome is due to sepsis, bleeding, dehy-
dratation and multisystem organ failure.
Recently it has been shown that plasma citrulline, a non-
protein amino acid product of glutamine metabolism in small
bowell enterocytes, is a reliable marker of anatomic entero-
cyte mass.17 Radiation-induced enterocyte damage and the
consequently reduction in small-bowell epithelial cell mass
candecrease citrulline concentration. Citrulline concentration
signiﬁcantly decrease as a function of the radiation dose and
the volume of small bowel treated and it has been proposed
as a biomarker for radiation-induced small-intestinalmucosal
damage.18
6. Neurovascular syndrome
The exact pathobiology of cerebrovascular syndrome is by no
means clear. A hypothesis is the damaging effects of radiation
on endothelial cells and vascular leak with edema and conse-
quently an increase in intracranial pressure. Cerebrovascular
syndrome occurs at doses higher than 20Gy and is charac-
terized by a very short prodromal and latent phases followed
by neurological symptoms as headache, abnormal cognition,
neurological deﬁcits and ﬁnally somnolent state, loss of con-
sciousness and death.
7. Other signs and symptoms
The exact mechanism of radiation-induced nausea
and vomiting is poorly understood. It is believed that
enterochromafﬁn-like cells of the gastrointestinal tract
release 5-hydroxytryptamine (5-HT) also called serotonine in
response to radiation exposure and serotonine acts on the 5-
HT receptor cells stimulating the medullary vomiting center.
Serotonine can also be released after radiation exposure from
the chemoreceptor trigger zone located in the area postrema
at the base of the fourth ventricle.An indirect proof is the signiﬁcant beneﬁt obtained with
5-hydroxytryptamine receptor antagonists in the preven-
tion of nausea and emesis of patients treated with external
beam radiation therapy on the upper abdomen or total-body
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rradiation.19,20 The estimate dose threshold for vomiting at
he prodromal phase is 1.5Gy and the time of onset of vom-
ting is highly dependent on absorbed dose of acute external
xposure with a linear correlation (Table 1).21 The higher the
ose, the earlier onset of vomiting.
A cutaneous syndrome can be seen in the formof erythema
t doses around 3Gy. At higher doses basal layer stem cells
re sterilized dying by mitotic death and no cells will enter
n the differentiating compartment. Mature cells dying after
heir lifespan of around three weeks will be not replaced by
ew cells and clinical manifestations will appear at this time.
oist desquamation of the skin with pruritus, blisters, bullae
nd ulceration can be seen.
Moderate depilation due to radiation damage to hair follicle
ill appear within two weeks after an exposure of around 4Gy
ut can be complete and earlier than 10 days for doses higher
han 6–8Gy.
Parotiditis with gland tumefaction and slight pain can be
een after lowexposures of 2.00Gy. Radiation causes apoptotic
ell death of serous acinar cells in salivary glands causing
cute xerostomia. These damaged cells release their intra-
ellular amylase into the bloodstream. Changes in the serum
mylase following irradiation of the salivary glands was ﬁrst
escribed by Kasima in 1965 showing a maximal increase
n amylasemia 24h after irradiation depending on dose and
olume of gland irradiated.22 It has been shown a sigmoid
elationship between dose to parotids and hyperamylasemia
ith no signiﬁcant increase in serum enzyme levels for doses
ower than 1Gy and a maximum level between doses of 4 and
0Gy.23 However, a wide interindividual variability precludes
ts use as a biological dosimeter.
. Multi-cellular target theory
ld thinking about the physiopathology of normal tissue radi-
tion toxicity has changed in the last years because our
etter understanding of radiation injury mechanisms at a
olecular level. At present it is believed that normal tis-
ue response to radiation is an integrated response involving
ell death (target cell theory) but also the production of
ytokines, reactive oxygen species and alterations in gene
xpression of many cells. A part from cytocidal effects, radi-
tion can produce indirect and functional effects. Examples
f indirect effect are the bystander effect and the secretion
f pro-inﬂammatory cytokines that can induce an inﬂam-
atory response. For instance, endothelial radiation-induced
ysfunction can produce leucocyte adhesion and chemotaxis
ith cytokine production and reactive oxygen species gener-
tion. These changes produce an oxidative imbalance with
ypercoagulability, leucocyte chemotaxis and again cytokine
roduction leading to an inﬂammatory response. Functional
ffects are non-lethal effects on different intracelular and
xtracelular molecules and changes in gene expression in
rradiated cells. Examples of functional effects are the acti-
ation of proteases or activation of latent growth factors.2 All
hese effects may lead to tissue injury with their correspond-
ng signs and symptoms that can be expressed after short or
ong period of time. This biological complexity means that ini-
ial radiation-induced damage, namely cytocidal, indirect ortherapy 1 6 ( 2 0 1 1 ) 123–130 129
functional effects is a continuum complex of events that can
be manifested in different ways and at different times.
9. Radiation-induced multi-organ
dysfunction (failure) syndrome
The dogma that failure of a single critical organ explains the
pathophysiology of acute radiation syndrome is today out-
dated. Recent advances in the study of clinical case histories
of patients involved in different radiation accidents occurred
between 1945 and 2000 showed that a part from classical
syndromes, other organs systems can be involved. In par-
ticular signs or symptoms due to cardiovascular, respiratory,
liver and urogenital damage can also be seen. These obser-
vations leads to the concept of radiation-induced multi-organ
involvement (RI-MOV) and multi-organ failure (RI-MOF).3,24,25
The hypothesis is that the symptomatology of organ system
involvement is not only due to the radiation-induced deple-
tion of proliferating cells of rapid turnover tissues but also
due to radiation-induced changes in the vascular system and
speciﬁcally in the endothelial cells leading the development
of an uncontrolled systemic inﬂammatory response. More-
over, the last two reported examples of large-ﬁeld high-dose
accidental irradiation in Tokai-mura and Nesvizh showed that
after appropriate and extensive treatment, it is possible to
“bridge” the acute phase of radiation-induced hematopoietic
and gastrointestinal syndromes but sequentially new clinical
ﬁndings involving other organs and cell system appear.26,27
For instance, it appears that cytokines play a central role in
mediating central nervous system response following irradi-
ation. It has been shown that radiation response of central
nervous system is characterized by local production of pro-
inﬂammatory cytokines in different brain structures causing
a stimulation of inﬂammatory cascade, interaction with other
inﬂammatory mediators and upregulation of the inﬂam-
matory process that leads to neurotoxicity.28 In the same
way, radiation-induced endothelial dysfunction can cause
increasedpermeability, endothelial cell apoptosis, coagulation
disorders, the expression of adhesion molecules, inﬂam-
matory cytokines and chemokines with transmigration of
leukocytes and the release of proteases and reactive oxygen
species that can contribute to tissue injury.29 These alter-
ations in endothelial cell integrity and function could play
a critical role in mediating organ dysfunction after acute
radiation exposure. An extensive review of the hypothet-
ical pathways involved in the initiation and development
of radiation-induced multi-organ dysfunction syndrome has
been recently published and is highly recommended.30
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